Search Results
Results found for "Denise Wootten"
- Are You Guessing or Forecasting? Master GPCR Pharmacologic Models Before It’s Too Late
clarity in GPCR drug discovery Even the strongest GPCR programs stall—not from bad data, but from buried decisions
- Why Mastering Pharmacokinetics Fundamentals Still Defines Discovery Success Today
dominates for many small molecules, but protein binding, transporters, and tissue architecture play decisive carry confounders Data quality hinges on experimental design and interpretive skepticism Tools inform decisions
- Immunomodulatory Role of Neuropeptides in the Cornea
September 2022 "The transparency of the cornea along with its dense sensory innervation and resident The cornea is the most densely innervated tissue of the body and possesses both immune and vascular privilege
- When the Islet Lit Up: Advancing GPCR Imaging in Native Tissue
For GPCR imaging, their strengths are practical and decisive: Consistency from batch to batch Long-term Imaging Possible Behind every technical advance in this story sits something less tangible but equally decisive
- Predicting GPCR Function: Inside the Carlsson Lab’s Modeling Toolbox
docking, and machine learning can transform GPCR research from descriptive science into predictive decision-making For industry leaders, this is an operational opportunity: integrate prediction into decision-making.
- Understanding the Journey: Catherine Demery's Path to Addiction Science
chose to write a review on genetic variation in susceptibility to alcoholism and opioid addiction—a decision Catherine's decision to defer pharmacy school was a leap of faith that opened new doors.
- First AMA of 2026: GPCR Pharmacology, Biased Signaling & Mechanistic Clarity
scientists working in GPCR programs, this connects functional assay data directly to translational decision-making
- The Hidden Driver of GPCR Drug Success: Why Target Residence Time Matters More Than You Think
delivers every week: practical tools and critical intelligence to elevate your science and sharpen your decisions GPCR scientists, translational pharmacologists, biotech discovery teams, and decision-makers who need
- When Pain Becomes a Catalyst: How Personal Experience Redefined One Scientist’s Mission
Denied stronger medication in the midst of the opioid crisis, he turned to the one place that still offered
- Beyond Clearance: The Strategic Power of Irreversible Drug Binding
. ✅ Decision speed to prioritize smarter leads and avoid avoidable attrition. Decades of kinetic insight reframed into actionable tools for faster, cleaner decision-making.
- Assay Sensitivity: The Hidden Lever Driving GPCR Drug Discovery
These aren’t abstract academic puzzles—they’re decision points that can make or break a program. What emerges is not just more data—it’s the right data, positioned to inform strategic decision-making
- Terry’s Corner, Celtarys' Leap, and the $7B GPCR Horizon
design, weekly lesson help you apply key concepts like binding, signaling, and kinetics in practical, decision-shaping
- Emerging approaches for decoding neuropeptide transmission
Neuropeptides exhibit distinct characteristics which includes their post-translational processing, release from dense
- GPCR Pharmacology Insights That Prevent Real Drug Discovery Failures
Teams equipped with deep GPCR pharmacology insights make different decisions. Kenakin revealed the decision workflow for ranking agonists with translational intent.
- Using Live-cell High-Content Screening to Characterize CB2 Ligands: Insights From 16 Synthetic Cannabinoids
receptor conformation affect signaling outcomes, a whole-cell environment can strengthen early-stage decision-making formats Why image-based confirmation (and transparent Ki reporting) can strengthen medicinal chemistry decisions
- The Imprecision Problem: Why Your GPCR Drug Discovery Program Is Off-Track Before It Even Starts
Ambiguous Decision Gates: Molecules advance or stall based on vibes, not criteria.
- Reflections on My PhD Journey: Lessons Learned
It was one of the best decisions I’ve made.
- Asking Better Questions in Science: A Practical Guide for Emerging Researchers
Better questions lead to better data, faster decisions, and fewer wrong turns.
- From Pipettes to Platforms: The Evolution of GPCR Research
technical rigor as foundation Technology boom — scaling curiosity Strategic shift — experiments as decisions
- How GPCR Spatial Signaling Sparked a Scientific Journey
Curiosity wasn’t just something Michelle felt — it started steering every decision she made.
- Molecular creativity in drug discovery
GPCR scientists, translational pharmacologists, biotech drug discovery teams, and decision-makers who
- Why “Displacement” Misleads You: Allosteric Binding Demystified
Terry’s Corner is built for scientists who want to move faster , think sharper , and make smarter decisions
- GPCR Allosteric Modulation: Why Allostery is the Engine of Drug Discovery
to shape future topics Built for discovery-phase teams, pharmacologists refining their methods, and decision-makers
- How System-Level GPCR Thinking Prevents Discovery Failures
Researchers, pharmacologists, biotech teams, and decision-makers who rely on accurate, efficient, interpretation-first
- Innovative Data-Driven Solutions: The pHSense Revolution
They constructed the platform, tested every variable—pKa, brightness, lifetime—and made decisions that
- How Breakthroughs Happen: Eric Trinquet on Innovation, Serendipity & GPCRs
It also requires months—often years—of decisions, missteps, and refinements.
- Chemical Drug Matter : Rethinking the Molecules We Choose to Develop In Drug Discovery
Terry’s Corner is a continuously growing knowledge platform built for scientists who want sharper decision-making
- How a Failed Med School Dream Sparked a GPCR Biotech Revolution
chronic pain, addiction, or another unmet need, keeping the real-world impact in focus can clarify career decisions
- When January Looks Different by March: Orthosteric vs. Allosteric Insights from Our Latest AMA
Each experimental decision — system sensitivity, assay configuration, kinetic design — carries strategic
- What's Going On with GPCRs?! Find Out in This Week's Update! ⦿ Nov 4 - 10, 2024
This strategic decision to limit free content is essential as we need to increase revenue to support



























